BOOK REVIEWS: New Antiepileptic Drugs. Supplement to Epilepsy Research, 3

Millac, Paul
June 1992
Journal of Neurology, Neurosurgery & Psychiatry;Jun1992, Vol. 55 Issue 6, p526
Book Review
No abstract available.


Related Articles

  • Chapter 34: Toward a Cure for Epilepsy.  // Epilepsy (9781932603415);2008, p329 

    Chapter 34 of the book "Epilepsy: Patient & Family Guide," Third Edition, by Orrin Devinsky is presented. It discusses the research toward a cure for epilepsy. It states that new antiepileptic drugs (AEDs) help people with difficult-to-control seizures and offer alternatives for those suffering...

  • Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies. Verrotti, Alberto; Greco, Rita; Giannuzzi, Raffaella; Chiarelli, Francesco; Latini, Giuseppe // Current Clinical Pharmacology;Sep2007, Vol. 2 Issue 3, p249 

    Generalized epilepsies are a large group of epilepsies with different clinical aspects and prognosis. Many antiepileptic drugs are available for the treatment of these seizures. This paper reviews the evidence relating to the treatment of this group of epilepsies. Historically, the great...

  • Drug trials in epilepsy. Mignot, Gilles // BMJ: British Medical Journal (International Edition);11/09/96, Vol. 313 Issue 7066, p1158 

    Argues that new antiepileptic drugs have been poorly assessed. Impact of poor assessment on drug treatment for epilepsy; Grounds for concern in epilepsy treatment.

  • Epilepsy.  // Current Medical Literature: Neurology;2008, Vol. 24 Issue 2, p54 

    This section presents abstracts of research on epilepsy which include ornithine transcarbamylase deficiency, response of patients to antiepileptic drugs, and estimating cost of epilepsy in Europe.

  • New antiepileptic drugs: A systematic review of their efficacy and tolerability. Marson, A.G.; Kadir, Z.A. // BMJ: British Medical Journal (International Edition);11/09/96, Vol. 313 Issue 7066, p1169 

    Evaluates the efficacy and tolerability of the newly developed antiepileptic drugs gabapentin, lamotrigine, tiagabine, topiramate, vigabatrin and zonisamide in patients with refractory partial epilepsy. Review of published and unpublished randomized controlled trials of add-on treatment with...

  • Three New Drugs for Epilepsy: Levetiracetam, Oxcarbazepine, and Zonisamide. Leppik, Ilo E. // Journal of Child Neurology;Jan2002 Supplement 1, Vol. 17, pS53 

    During the last decade, nine new antiepileptic drugs were approved for use by the US Food and Drug Administration. The characteristics of three of these new antiepileptic drugs — levetiracetam, oxcarbazepine, and zonisamide — are reviewed here. Their individual characteristics,...

  • When do epileptic patients need treatment? Starting and stopping medication. Chadwick, D.; Reynolds, E.H. // British Medical Journal (Clinical Research Edition);6/22/1985, Vol. 290 Issue 6485, p1885 

    Investigates the considerations in the antiepileptic treatments for patients with epilepsy. Administration of antiepileptic drugs prior to the occurrence of seizures; Adverse effects of antiepileptic drugs; Prognosis of epilepsy.

  • Advances in epilepsy. Kelso, Andrew R. C.; Cock, Hannah R. // British Medical Bulletin;Jan2005, Vol. 72 Issue 1, p135 

    Advances in understanding of both the causes and consequences of epilepsy have been paralleled by a number of recent reports and clinical guidelines highlighting the complexities involved in both diagnosing and treating epilepsy. We review recent developments, including comments on the evolution...

  • AAN/AES Guidelines on Use of New AEDS. Ben-Menachem, Elinor // Epilepsy Currents;Jan/Feb2005, Vol. 5 Issue 1, p30 

    Presents a study which assessed the evidence demonstrating efficacy, tolerability and safety of several antiepileptic drugs. Drugs approved by the U.S. Food and Drug Administration for the treatment of children and adults with newly diagnosed partial and generalized epilepsies; Guidelines used...

  • AEs observed with antiepileptics not due to coprescribing.  // Reactions Weekly;7/10/2010, Issue 1309, p6 

    The article discusses a research study which revealed that the adverse events (AEs) burden of antiepileptic drugs are associated to individual responsiveness, type of antiepileptic drug/s chosen and physician skills than to the number of coprescribed antiepileptic drugs or drug load among...


Read the Article


Sign out of this library

Other Topics